NO157643C - Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater. - Google Patents

Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater.

Info

Publication number
NO157643C
NO157643C NO812556A NO812556A NO157643C NO 157643 C NO157643 C NO 157643C NO 812556 A NO812556 A NO 812556A NO 812556 A NO812556 A NO 812556A NO 157643 C NO157643 C NO 157643C
Authority
NO
Norway
Prior art keywords
acid
tienopyridine
literic
degradation
derivatives
Prior art date
Application number
NO812556A
Other languages
English (en)
Norwegian (no)
Other versions
NO157643B (no
NO812556L (no
Inventor
Zaka-Ud-Din T Chowhan
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22631437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO157643(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO812556L publication Critical patent/NO812556L/no
Publication of NO157643B publication Critical patent/NO157643B/no
Publication of NO157643C publication Critical patent/NO157643C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
NO812556A 1980-07-29 1981-07-27 Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater. NO157643C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17331080A 1980-07-29 1980-07-29

Publications (3)

Publication Number Publication Date
NO812556L NO812556L (no) 1982-02-01
NO157643B NO157643B (no) 1988-01-18
NO157643C true NO157643C (no) 1988-04-27

Family

ID=22631437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812556A NO157643C (no) 1980-07-29 1981-07-27 Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater.

Country Status (16)

Country Link
EP (1) EP0045238B1 (fr)
JP (1) JPS5753414A (fr)
AT (1) ATE22530T1 (fr)
AU (1) AU546492B2 (fr)
CA (1) CA1176170A (fr)
DE (1) DE3175410D1 (fr)
DK (1) DK159590C (fr)
GB (1) GB2080683B (fr)
GR (1) GR74953B (fr)
IE (1) IE51419B1 (fr)
IL (1) IL63315A (fr)
NO (1) NO157643C (fr)
NZ (1) NZ197783A (fr)
PH (1) PH17017A (fr)
PT (1) PT73442B (fr)
ZA (1) ZA814950B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
DE3320582A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
JPH075464B2 (ja) * 1985-07-08 1995-01-25 中外製薬株式会社 安定なニコランジル製剤
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
KR950010150B1 (ko) * 1986-01-14 1995-09-11 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 함유 주사제의 안정화 방법
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
US5684121A (en) * 1994-12-06 1997-11-04 Isp Investments Inc. N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution
EP1005864A1 (fr) * 1998-11-30 2000-06-07 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Compositions pharmaceutiques stables dépourvues d'antioxidant contenant des dérivés thiènopyridine
FR2789589A1 (fr) * 1999-02-16 2000-08-18 Igen Procede de conditionnement de compositions pharmaceutiques et compositions de ticlopidine obtenues par ce procede.
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤
WO2011052499A1 (fr) * 2009-10-28 2011-05-05 第一三共株式会社 Composition pharmaceutique présentant une stabilité au stockage améliorée
WO2017131001A1 (fr) * 2016-01-25 2017-08-03 サントリーホールディングス株式会社 Composition comprenant une capsule en gélatine d'acide ellagique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE585778A (fr) * 1958-04-18
DE2157201C3 (de) * 1970-11-13 1974-12-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verbesserte feste orale Applikationsform von Raubasin
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire
GB1498857A (en) * 1975-07-03 1978-01-25 Leo Ab Antidepressant composition
FR2358150A1 (fr) * 1976-07-13 1978-02-10 Parcor Nouvelles thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application

Also Published As

Publication number Publication date
EP0045238A2 (fr) 1982-02-03
NO157643B (no) 1988-01-18
GB2080683A (en) 1982-02-10
GR74953B (fr) 1984-07-12
DK159590B (da) 1990-11-05
GB2080683B (en) 1984-09-19
AU7351881A (en) 1982-09-23
IE51419B1 (en) 1986-12-24
DK159590C (da) 1991-04-08
DK321081A (da) 1982-01-30
CA1176170A (fr) 1984-10-16
AU546492B2 (en) 1985-09-05
EP0045238B1 (fr) 1986-10-01
DE3175410D1 (en) 1986-11-06
JPH0243725B2 (fr) 1990-10-01
IL63315A (en) 1984-03-30
PT73442B (en) 1983-02-16
IL63315A0 (en) 1981-10-30
IE811650L (en) 1982-01-29
JPS5753414A (en) 1982-03-30
ZA814950B (en) 1982-08-25
PT73442A (en) 1981-08-01
NZ197783A (en) 1984-03-30
EP0045238A3 (en) 1983-02-16
ATE22530T1 (de) 1986-10-15
NO812556L (no) 1982-02-01
PH17017A (en) 1984-05-11

Similar Documents

Publication Publication Date Title
NO157643C (no) Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater.
SE8106642L (sv) Piperazinylbensoheterocykliska foreningar och forfarande for framstellning derav
DE69027235D1 (de) Xanthinderivate
NO157979C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzotiazindioksyd-salter.
RU92016595A (ru) Замещенные тиазолильные и замещенные пиридинильные производные, фармацевтическая композиция и способ их получения
ATE159258T1 (de) 4-desoxy-4-epipodophyllotoxinderivate oder deren pharmazeutisch akzeptierbaren salze
ATE147625T1 (de) Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
SE7411243L (fr)
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
SE7910554L (sv) Disulfidforeningar
DE69132578D1 (de) Cephemderivate
DK339783A (da) Analogifremgangsmaade til fremstilling af 3-beta-(3-carboxypropionyloxy)ursa-9(11),12-dien-28-syre
DK412985A (da) Prolinforbindelse og farmaceutisk praeparat indeholdende forbindelsen
DK34882A (da) Fremgangsmaade til fremstilling af peptidderivater
IE43848L (en) Pharmaceutical compositions
ES8403135A1 (es) Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico.
IT1247983B (it) Derivati di una pirrolo-piridina, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono.